New detection configuration for low activity levels of PET tracers during the analysis of plasma samples.


Journal

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 10 09 2018
revised: 21 03 2019
accepted: 16 05 2019
pubmed: 4 8 2019
medline: 27 2 2020
entrez: 4 8 2019
Statut: ppublish

Résumé

A new radio-HPLC detection system for measuring radioactivity in plasma samples during Positron Emission Tomography [PET] studies was developed. It is based on detecting both the positron and one of the annihilation photons. The system focused on improving the measurement of radioactivity concentrations on an unmetabolized positron emitting a radiopharmaceutical [PER] in the presence of its radioactive metabolites, all containing the same positron emitter. This paper presents a new detection configuration that improves the minimal detectible activity (MDA), simplify the measuring systems and reduces the error caused by the metabolites. The detector is based on a plastic scintillator and a BGO scintillation crystal, that produces different light output spectra for signal and noise events. By summing the positron and the annihilated photon light outputs, different spectra are obtained for the metabolite and for the parent compound tracer and for tracer marked by different positron emitting isotopes. This new detection system can improve quantitative analysis of plasma samples. The spectrum change provides up to a three-fold improvement in sensitivity compared to the currently used detection systems that measure only the annihilation coincidence events. Results showed that for

Identifiants

pubmed: 31376719
pii: S0969-8043(18)30827-3
doi: 10.1016/j.apradiso.2019.05.025
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-330

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

A Osovizky (A)

Jerry J. Cohen Radiobiology Research Laboratory, Nuclear Engineering Department, Ben-Gurion University of the Negev, Israel; Centre for Addiction and Mental Health, Toronto, Canada; Rotem Industries Ltd, Beer-Sheva, Israel. Electronic address: alon@rotemi.co.il.

B Laster (B)

Jerry J. Cohen Radiobiology Research Laboratory, Nuclear Engineering Department, Ben-Gurion University of the Negev, Israel.

A A Wilson (AA)

Centre for Addiction and Mental Health, Toronto, Canada.

P Bloomfield (P)

Centre for Addiction and Mental Health, Toronto, Canada.

B Sarusi (B)

Rotem Industries Ltd, Beer-Sheva, Israel.

N Vasdev (N)

Centre for Addiction and Mental Health, Toronto, Canada.

T Bell (T)

Centre for Addiction and Mental Health, Toronto, Canada.

A Garcia (A)

Centre for Addiction and Mental Health, Toronto, Canada.

S Houle (S)

Centre for Addiction and Mental Health, Toronto, Canada; University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH